Amedisys (NASDAQ:AMED) Lowered to “Market Perform” at William Blair

Amedisys (NASDAQ:AMED) was downgraded by research analysts at William Blair from an “outperform” rating to a “market perform” rating in a report issued on Monday, Briefing.com reports.

A number of other analysts have also recently weighed in on the company. Royal Bank of Canada boosted their price target on Amedisys from $97.00 to $100.00 and gave the stock an “outperform” rating in a research report on Monday, March 25th. Cantor Fitzgerald reissued a “neutral” rating and issued a $101.00 price target on shares of Amedisys in a research note on Thursday, April 25th. StockNews.com raised Amedisys from a “hold” rating to a “buy” rating in a research note on Saturday, May 4th. Finally, Raymond James reaffirmed a “market perform” rating on shares of Amedisys in a research note on Tuesday, March 26th. Five research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat, Amedisys has an average rating of “Hold” and a consensus target price of $100.67.

Amedisys Stock Down 1.3 %

AMED opened at $91.80 on Monday. Amedisys has a one year low of $89.55 and a one year high of $97.36. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.09 and a current ratio of 1.09. The stock’s fifty day moving average is $93.09 and its 200-day moving average is $93.43. The company has a market capitalization of $3.00 billion, a PE ratio of -143.44, a P/E/G ratio of 2.25 and a beta of 0.80.

Amedisys (NASDAQ:AMED) last posted its quarterly earnings data on Wednesday, April 24th. The health services provider reported $1.03 EPS for the quarter, topping analysts’ consensus estimates of $1.02 by $0.01. The company had revenue of $571.41 million for the quarter, compared to the consensus estimate of $565.38 million. Amedisys had a positive return on equity of 12.85% and a negative net margin of 0.91%. The company’s quarterly revenue was up 2.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.00 EPS. On average, equities analysts predict that Amedisys will post 4.57 EPS for the current fiscal year.

Hedge Funds Weigh In On Amedisys

A number of hedge funds and other institutional investors have recently bought and sold shares of AMED. Vanguard Group Inc. lifted its position in Amedisys by 0.4% during the third quarter. Vanguard Group Inc. now owns 3,241,160 shares of the health services provider’s stock worth $302,724,000 after acquiring an additional 12,137 shares during the last quarter. Alpine Associates Management Inc. lifted its position in Amedisys by 23.0% during the fourth quarter. Alpine Associates Management Inc. now owns 1,271,097 shares of the health services provider’s stock worth $120,830,000 after acquiring an additional 237,600 shares during the last quarter. Westchester Capital Management LLC lifted its position in Amedisys by 3.4% during the fourth quarter. Westchester Capital Management LLC now owns 879,402 shares of the health services provider’s stock worth $83,596,000 after acquiring an additional 29,016 shares during the last quarter. Park West Asset Management LLC lifted its position in Amedisys by 8.0% during the fourth quarter. Park West Asset Management LLC now owns 812,069 shares of the health services provider’s stock worth $77,195,000 after acquiring an additional 60,350 shares during the last quarter. Finally, Water Island Capital LLC lifted its position in Amedisys by 185.0% during the fourth quarter. Water Island Capital LLC now owns 710,697 shares of the health services provider’s stock worth $67,559,000 after acquiring an additional 461,368 shares during the last quarter. Institutional investors own 94.36% of the company’s stock.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.